Key Benefits
• Restores ampicillin-induced gut microbiota dysbiosis• Effectively alleviates antibiotic-associated diarrhea• Improves overall intestinal function
Key Data
• Short generation time (fast growth)• Simulated gastric fluid survival: 86%• Simulated intestinal fluid survival: 93%• HT-29 cell adhesion: 30 bacteria/cell (excellent adhesion)• Low drug resistance – safe for long-term use• Demonstrated efficacy in restoring microbiota balance in antibiotic-treated mice
Patent
National Invention Patent – A Lactobacillus plantarum strain for regulating ampicillin-induced gut microbiota dysbiosis
Why Choose CCFM602?
Specifically targets antibiotic-associated diarrhea – a common side effect of medication use, especially in children and the elderly
Excellent survival and adhesion ensures effective delivery and colonization in the gut
Ideal for post-antibiotic recovery formulas, digestive health products, and pediatric probiotic blends